Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Rhythm Pharmaceuticals
RYTM
$6.66B
| $1.38M | ﹤0.01% |
47,491
+7,201
| +18% | +$210K |
|
|
ILPT
2502
Industrial Logistics Properties Trust
ILPT
$415M
| $1.38M | ﹤0.01% |
422,372
-124,509
| -23% | -$407K |
|
2503
Beazer Homes USA
BZH
$758M
| $1.38M | ﹤0.01% |
107,942
-19,049
| -15% | -$243K |
|
|
CSTR
2504
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.37M | ﹤0.01% |
77,789
-6,231
| -7% | -$110K |
|
|
TVRD
2505
Tvardi Therapeutics, Inc. Common Stock
TVRD
$308M
| $1.37M | ﹤0.01% |
3,545
-567
| -14% | -$219K |
|
2506
KRONOS Worldwide
KRO
$721M
| $1.37M | ﹤0.01% |
145,642
+49,070
| +51% | +$461K |
|
2507
Allogene Therapeutics
ALLO
$246M
| $1.37M | ﹤0.01% |
217,349
-129,820
| -37% | -$816K |
|
2508
Transcat
TRNS
$705M
| $1.37M | ﹤0.01% |
19,261
-1,087
| -5% | -$77K |
|
2509
Lindblad Expeditions
LIND
$717M
| $1.36M | ﹤0.01% |
177,137
+14,679
| +9% | +$113K |
|
|
GOEV
2510
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.36M | ﹤0.01% |
2,409
+1,178
| +96% | +$667K |
|
2511
Capital City Bank Group
CCBG
$737M
| $1.36M | ﹤0.01% |
41,863
-5,465
| -12% | -$178K |
|
2512
F&G Annuities & Life
FG
$4.62B
| $1.36M | ﹤0.01% |
+67,981
| New | +$1.36M |
|
2513
Unisys
UIS
$276M
| $1.36M | ﹤0.01% |
265,997
-11,967
| -4% | -$61.2K |
|
2514
Origin Materials
ORGN
$80.2M
| $1.36M | ﹤0.01% |
294,625
-41,532
| -12% | -$192K |
|
2515
Bionano Genomics
BNGO
$23M
| $1.36M | ﹤0.01% |
1,548
-197
| -11% | -$173K |
|
|
BBUC
2516
Brookfield Business Corp
BBUC
$2.36B
| $1.36M | ﹤0.01% |
72,094
-4,061
| -5% | -$76.3K |
|
2517
Peoples Financial Services
PFIS
$524M
| $1.36M | ﹤0.01% |
26,143
-4,048
| -13% | -$210K |
|
2518
Destination XL Group
DXLG
$67.9M
| $1.35M | ﹤0.01% |
200,370
-11,786
| -6% | -$79.6K |
|
|
NPKI
2519
NPK International Inc.
NPKI
$899M
| $1.35M | ﹤0.01% |
324,182
-45,986
| -12% | -$191K |
|
|
ME
2520
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $1.35M | ﹤0.01% |
31,178
-13,360
| -30% | -$577K |
|
|
CMRC
2521
Commerce.com, Inc. Series 1 Common Stock
CMRC
$365M
| $1.35M | ﹤0.01% |
153,935
-8,144
| -5% | -$71.2K |
|
2522
Generation Bio
GBIO
$40.3M
| $1.34M | ﹤0.01% |
34,206
-1,659
| -5% | -$65.2K |
|
2523
Noodles & Co
NDLS
$30.6M
| $1.34M | ﹤0.01% |
244,255
+3,106
| +1% | +$17.1K |
|
|
DX
2524
Dynex Capital
DX
$1.65B
| $1.34M | ﹤0.01% |
105,358
-14,423
| -12% | -$183K |
|
2525
SmartFinancial
SMBK
$627M
| $1.34M | ﹤0.01% |
48,632
-7,046
| -13% | -$194K |
|